10.15 USD
+1.2 (+13.41%)
10.2 USD
+0.05 (+0.49%)
ChartMill assigns a Buy % Consensus number of 53% to RXST. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 9.86. This target is -2.86% below the current price.
RXST was analyzed by 16 analysts. The buy percentage consensus is at 53. So analysts seem to be rather neutral about RXST.
In the previous month the buy percentage consensus was at a similar level.
RXST was analyzed by 16 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-06 | Needham | Maintains | Buy -> Buy |
| 2025-11-06 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-11-06 | JP Morgan | Maintains | Underweight -> Underweight |
| 2025-08-08 | UBS | Maintains | Neutral -> Neutral |
| 2025-08-08 | Needham | Maintains | Buy -> Buy |
| 2025-08-08 | Stifel | Maintains | Hold -> Hold |
| 2025-07-15 | Morgan Stanley | Downgrade | Overweight -> Equal-Weight |
| 2025-07-10 | Jefferies | Downgrade | Buy -> Hold |
| 2025-07-09 | BTIG | Downgrade | Buy -> Neutral |
| 2025-07-09 | Needham | Reiterate | Buy -> Buy |
| 2025-07-09 | Stifel | Maintains | Hold -> Hold |
| 2025-07-09 | Wells Fargo | Downgrade | Overweight -> Equal-Weight |
| 2025-07-09 | B of A Securities | Maintains | Underperform -> Underperform |
| 2025-07-09 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2025-05-19 | Wells Fargo | Upgrade | Equal-Weight -> Overweight |
| 2025-04-15 | Piper Sandler | Initiate | Neutral |
| 2025-04-09 | UBS | Downgrade | Buy -> Neutral |
| 2025-04-08 | Needham | Maintains | Buy -> Buy |
| 2025-04-07 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-04-04 | JP Morgan | Downgrade | Overweight -> Underweight |
| 2025-04-03 | Needham | Reiterate | Buy -> Buy |
| 2025-04-03 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-03-21 | B of A Securities | Maintains | Buy -> Buy |
| 2025-03-19 | Stifel | Maintains | Hold -> Hold |
| 2025-02-26 | Needham | Reiterate | Buy -> Buy |
| 2025-02-26 | Stifel | Maintains | Hold -> Hold |
| 2025-02-26 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-02-26 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-01-13 | Needham | Reiterate | Buy -> Buy |
| 2025-01-13 | Stifel | Maintains | Hold -> Hold |
RXSIGHT INC / RXST FAQ
What is the average price target for RXSIGHT INC (RXST) stock?
16 analysts have analysed RXST and the average price target is 9.86 USD. This implies a price decrease of -2.86% is expected in the next year compared to the current price of 10.15.
How do analysts rate RXSIGHT INC (RXST)?
The consensus rating for RXSIGHT INC (RXST) is 52.5 / 100 . This indicates that analysts generally have a neutral outlook on the stock.
How many analysts cover RXSIGHT INC (RXST) stock?
The number of analysts covering RXSIGHT INC (RXST) is 16.